ID   FSO1_OMPOL              Reviewed;        4547 AA.
AC   Q52US9;
DT   23-MAY-2018, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 70.
DE   RecName: Full=Nonribosomal peptide synthase fso1 {ECO:0000303|PubMed:16019163};
DE            EC=6.3.2.- {ECO:0000305|PubMed:16019163};
DE   AltName: Full=Ferrichrome A biosynthesis cluster protein fso1 {ECO:0000303|PubMed:16019163};
DE   AltName: Full=Ferrichrome A synthetase {ECO:0000303|PubMed:16019163};
GN   Name=fso1 {ECO:0000303|PubMed:16019163};
OS   Omphalotus olearius (Jack o'lantern).
OC   Eukaryota; Fungi; Dikarya; Basidiomycota; Agaricomycotina; Agaricomycetes;
OC   Agaricomycetidae; Agaricales; Omphalotaceae; Omphalotus.
OX   NCBI_TaxID=72120;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, INDUCTION, AND DOMAIN.
RC   STRAIN=TA90170;
RX   PubMed=16019163; DOI=10.1016/j.femsle.2005.06.013;
RA   Welzel K., Eisfeld K., Antelo L., Anke T., Anke H.;
RT   "Characterization of the ferrichrome A biosynthetic gene cluster in the
RT   homobasidiomycete Omphalotus olearius.";
RL   FEMS Microbiol. Lett. 249:157-163(2005).
RN   [2]
RP   DOMAIN.
RX   PubMed=16502473; DOI=10.1002/cbic.200500301;
RA   Schwecke T., Goettling K., Durek P., Duenas I., Kaeufer N.F.,
RA   Zock-Emmenthal S., Staub E., Neuhof T., Dieckmann R., von Doehren H.;
RT   "Nonribosomal peptide synthesis in Schizosaccharomyces pombe and the
RT   architectures of ferrichrome-type siderophore synthetases in fungi.";
RL   ChemBioChem 7:612-622(2006).
CC   -!- FUNCTION: Nonribosomal peptide synthase; part of the siderophore
CC       biosynthetic pathway (PubMed:16019163). Omphalotus olearius produces
CC       ferrichrome A, but no other siderophore has been detected
CC       (PubMed:16019163). Ferrichrome A consists of a hexapeptide ring made up
CC       of one glycine, two serine, and three N(5)-hydroxyornithine amino acid
CC       residues, the latter acylated by trans-(alpha-methyl)-glutaconic acid
CC       residues (PubMed:16019163). The biosynthesis of ferrichrome A depends
CC       on the hydroxylation of ornithine to N(5)-hydroxyornithine, catalyzed
CC       by the monooxygenase omo1 (PubMed:16019163). The second step, the
CC       acylation of N(5)-hydroxy-L-ornithine is probably catalyzed by the N-
CC       acyltransferase ato1 (PubMed:16019163). Finally, assembly of
CC       ferrichrome A is catalyzed by the nonribosomal peptide synthase (NRPS)
CC       fso1 (PubMed:16019163). {ECO:0000269|PubMed:16019163}.
CC   -!- PATHWAY: Siderophore biosynthesis; ferrichrome biosynthesis.
CC       {ECO:0000305|PubMed:16019163}.
CC   -!- INDUCTION: Expression is iduced under iron-depleted conditions
CC       (PubMed:16019163). {ECO:0000269|PubMed:16019163}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module (By similarity). Each module is responsible for the recognition
CC       (via the A domain) and incorporation of a single amino acid into the
CC       growing peptide product (By similarity). Thus, an NRP synthetase is
CC       generally composed of one or more modules and can terminate in a
CC       thioesterase domain (TE) that releases the newly synthesized peptide
CC       from the enzyme (By similarity). Occasionally, methyltransferase
CC       domains (responsible for amino acid methylation) are present within the
CC       NRP synthetase (By similarity). Fso1 has the following architecture: A-
CC       T-C-A-T-C-A-T-C-T-C-T-C (PubMed:16019163, PubMed:16502473).
CC       {ECO:0000250|UniProtKB:A0A144KPJ6, ECO:0000305|PubMed:16019163,
CC       ECO:0000305|PubMed:16502473}.
CC   -!- SIMILARITY: Belongs to the NRP synthase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY929618; AAX49356.1; -; Genomic_DNA.
DR   SMR; Q52US9; -.
DR   UniPathway; UPA00783; -.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0031169; P:ferrichrome biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 1.10.1200.10; -; 5.
DR   Gene3D; 3.30.559.10; -; 5.
DR   Gene3D; 3.40.50.12780; -; 3.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; AMP-dep_Synthh-like_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   Pfam; PF00501; AMP-binding; 3.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   Pfam; PF00668; Condensation; 5.
DR   Pfam; PF00550; PP-binding; 5.
DR   SMART; SM00823; PKS_PP; 4.
DR   SUPFAM; SSF47336; SSF47336; 5.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 1.
DR   PROSITE; PS00455; AMP_BINDING; 2.
DR   PROSITE; PS50075; CARRIER; 5.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 3.
PE   2: Evidence at transcript level;
KW   Ligase; Multifunctional enzyme; Phosphopantetheine; Phosphoprotein; Repeat.
FT   CHAIN           1..4547
FT                   /note="Nonribosomal peptide synthase fso1"
FT                   /id="PRO_0000444315"
FT   DOMAIN          737..812
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:16019163, ECO:0000305|PubMed:16502473"
FT   DOMAIN          1823..1899
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:16019163, ECO:0000305|PubMed:16502473"
FT   DOMAIN          2910..2986
FT                   /note="Carrier 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:16019163, ECO:0000305|PubMed:16502473"
FT   DOMAIN          3440..3516
FT                   /note="Carrier 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:16019163, ECO:0000305|PubMed:16502473"
FT   DOMAIN          3998..4074
FT                   /note="Carrier 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:16019163, ECO:0000305|PubMed:16502473"
FT   REGION          200..612
FT                   /note="Adenylation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16019163,
FT                   ECO:0000305|PubMed:16502473"
FT   REGION          851..1259
FT                   /note="Condensation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16019163,
FT                   ECO:0000305|PubMed:16502473"
FT   REGION          1295..1693
FT                   /note="Adenylation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16019163,
FT                   ECO:0000305|PubMed:16502473"
FT   REGION          1930..2365
FT                   /note="Condensation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16019163,
FT                   ECO:0000305|PubMed:16502473"
FT   REGION          2390..2769
FT                   /note="Adenylation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16019163,
FT                   ECO:0000305|PubMed:16502473"
FT   REGION          3015..3429
FT                   /note="Condensation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16019163,
FT                   ECO:0000305|PubMed:16502473"
FT   REGION          3557..3967
FT                   /note="Condensation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16019163,
FT                   ECO:0000305|PubMed:16502473"
FT   REGION          4136..4461
FT                   /note="Condensation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16019163,
FT                   ECO:0000305|PubMed:16502473"
FT   MOD_RES         772
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         1860
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         2947
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3477
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         4035
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   4547 AA;  499822 MW;  769EFB27CC5A85AF CRC64;
     MSSLEGRFTL PATCIPCVFP RVISSTLNAR LDVITINSPE SKLDLVAFAT VLRALLATSG
     EFSFGLGKNQ FVVVESVDET EKEVEEKLSV HDASQVTGSE NVQARIDSDA LEIDGSVPSI
     VSSSQELVLF HLNAQPSSVS LVYSTDYIPD SLAKSLLELY FIKCAAKFDI GAISGALSIV
     NHPVQSVLSN RKPLLHAAFV ERADETPDAL AIDYLSAIDE YPLRKTLSYG DLDKYSLAVA
     RILRGIVPST EKAIVPLALP PSPELYIGYL ATLRAGYAFC PLPGCDAAPV ERIRELITDV
     SASVVLGLGS RPPWLADLGH IRWVDISLEA DNFALKSASL VDGQDWVEPE ADDLAYVLFT
     SGSTGKPKGV QITHLAAASS IAGHLAVRPL PPYTRWFQFA ASTFDPSLME TFMNLSSGTT
     ICAANRQRLL TDPESVLCEL ECTHMMATPS FAAMLRPERL GNTASKSFLE HGVKFELWTM
     GERLLEKVIA AFSRPDEGYV LCNAYGPTEA AINTTLRVHP RHETGARLGQ PIPSATMVIL
     HPTEPWLVPQ GFPGELGLAG PQLARGYLNM PDQTARAFVL VDGIGRVYRT GDKARLVPDS
     NNEWTCVEYL GRMGLGQVKL SGRRVELGEI DVVMASVPGV QSAHAIVHQQ SGNGAVQLVA
     FLTPDDEKLV EKVKAVVDAR LPQHMRPSRY FLGESVPRST SGKADRRAIG AVIASRIAQS
     DADNRTTDTE GEIVADREML ERIIKIVAET VDVLDNSAVT PISNLFDLGI DSLRGVRLLS
     LAREAGIQGL TIKDLLQNAT PIALVNALCS RQNDADSSQY LDTLLRFTAE AAPAVRRELS
     LSDNDPLPPI LPATPMQAGV LALYLRGGPA SKGYINHSVY KLASGIDLDR FKDSWVHIVQ
     RNDILHSRFV LVDNSATSPF AMVTLNDASV SWVERTGDDV EALVETYLKD IPSDFSLTSL
     KAFALLKNAD GSDVRFVLSL HHSISDGASL ALMLEELSLN YRGNDVSLRR EGFEHSVKDA
     LTADTDANTS YWKEQLEDFT PDAFPDLTGL RPSAKYTGHH VTTVISSMSF SNLLKTSRAL
     KSTPLAVLQA AWASILLAYS ESESPDIVFG SIVGGRSSEA LEYTVGPVFT AVPVRVRNVS
     GVTTGDLLST FVSNNVQGLV HRYPPVSVLS GSSGIIYDTT IALQHFGQEQ SQTALWTAAD
     YPAMETEFAV VLEVWPEEDD SIRLRATCSN HVLIPSASEA MLHQFDDILK FILENPAEAQ
     FANVTDGVRQ RLQSSINSHP QPFPVAPNTL IHHEFEQNAR LHPDALAIWF KEDIEHPEND
     IRWTYRELNE KANRLAHLLA STYGNLCDRA IPLCMEKCPE LYVAILGVLK AGAAWCPVDF
     AAPEMRKQNL FARAGGPVVL ISSNTEFSHI KAALPGGLDI FSLDDPRLND QPDSAPVIET
     TPSHLAYLIW TSGTTGLPKG VPIEHKAAVQ SLKVLQREIP HNTAVRCLNF SAYTFDVSVL
     DVFYALGSAC GTLCSSRKEI LVGKFAEAVN AFEATQAFLT PAFMTQSSLD ECRTLESLIS
     IGEKLPDTVA DKWCRPGTAS LNTYGPAEST IIATYRRFTP NDSTKAHNVG LPIQTVSCFA
     MKEGRIVPRG AVGELALGGY QNARGYHRQP DMTAKKFIEH PTAGSIYLTG DIVRFLHDGT
     CEFVGRNDDL VKLGGIRVEL SEISAALESC HPAVHEAVTI QLSRPDRPQK IVCTFVAAPG
     ISGDKNICIG TDAVEIACAA KERAELSLPV FMHPNVVIIV KRLPHTASNK IDRKALGEYY
     CDLDIMAWEN SLADHMGTGD IEATWSETEL KIRDTVSELT GSPKEWISKT THLPALGVDS
     IRALQLASRL RAIDVNISVQ DILQHSTIRQ LARQSETASS NLHNVISPWL EGFSSRWSPV
     VQRDFVEKVE RVLPCAPLQE GMLGESVKNP EAYWSHRLFP LNKNIDLGRL SNAWNTATEH
     YEILRVVFMP AAAYASSNVM ETDPNSVFLQ VLLSRYEVPS TRQQIGRSEV YSMAREYARN
     IAISRSRSLQ PRWSLIVLES TDGHSWMMFS MHHALYDAHA VTYLLADIQR RYHGISPSPQ
     LQLTSALSRT FFANGPQESL DVWRDILTPF ADRNALEWPT LTDGRSREDA RFFSSAFERD
     YFSLTELATK AGGTAGHVLQ AAWSIVSAAY LETDRVVFGE TLSLRLEDHE LQHAIAPLIT
     TKPVAAHLKG TTTPRVLIRE LADLTKLASL HRSIGFQHIR KILQRPINQP LFPSIFVIYF
     EEDSSVPSDI AENLWSSPHD VSSLGVEHPI AINVNVSGEK VVVNVLGNGA IMSESQVELL
     SQQFNAVLTR MLNEPDVPIM SLVSALDEMH LSIVKGASPM SQTHPLHWLE KFALTRPDAV
     AVSSYRSLSN EVPNEIWTYR ALEEASNRVA HWIRRRYHSG IVAFCMPRSH TSIVYQLGIF
     KSGNIYLPIG EEIPAFRKRL IFRTSQTSLV FTTKALLHEF KSLDKNAIIC VDDVQHLLEV
     SDSAITKPPL SIPETSCILV DDGHLCTSRA SLVSSQNLIS MVEGFVHEVY SSVLSLDENI
     FLSWMPSSAD IHLIELFAPL RMGMKSASIP HQFLHQDASA VFHRTGASHS FLTTLGLNRR
     FETVDLPSVK CAIFTGIPSR AALLKEWRNG QGLMVLRAFG FPGLFTLGQY EYDLPMNIGK
     PVNSCTTLVL RQDSSAITLR GEAGELCIAE DILSPQYSKA HVFTDTVGYG RVHRTRHVGR
     VRADDTIDYN GPINIYRNNA GQVIDLTELS ELLRSTSHLS IDVATFVFDH PEGIRNYIVS
     FVSRSSSADP LNGALPVVVV TDFAFTSNLL GHYKRHVSAH LVPDFIIPLD YLPLSSLATG
     RKHEARLKRV FHNFSLSALN QGSEKKRSAR SLTAVEEEIR AILSKTTGIP VQTIDADSTT
     IELGIDSLSA ISLSYQLKSA GYFVPPHVIL SGPSVAKLGK SSKAIVESNT KVLSSWEVED
     SIKKFVCEQL KVEVQSVLPC LPLQEGLIAH TLNSAKPIYV NHFVLRLDEA DPMLLRAAFE
     ETVKANDILR TCFVAANQNI VQAVLSETPE IWRSVSVESQ EDLLSKLRHD MAGVEHDVVQ
     NLGQKPPIRL GLYLSDSSPT YFCLTMHHAV YDGQSLSMLL SEVRDRYTGC FQIQRGSTSN
     FLNYLARQSQ DASRAFYSDY LHNIPRPPVS PFVDDTLSSH HQSLKLDVSL SHLERISRSV
     NASLHSLALA AFGVATAEYR KRNDLVIGVV LSGRSVLVDG IETMLAPCIT TVPVRVRTGK
     SEVFSDIAQR IHTEMSSLLA YQHTPLRLIQ RWLGSSEPLF DTLFSFNRMT TGSSSSTLWS
     SVESKAALDY PFALAIDADS TSDSLVIRAG HIPSFGSKAT VKTIMLRVAE LLANLDTRID
     LLVSHKLLET QEDSPMYDSS AWSQEEILIR NNVAEVCNVD RNLVTKDISF LHLGIDSITS
     IRLAQQLRNA GLAIPTFAIM RHPCVGALAE YLKDNPMVST SAIALRELNE IQEVLRKEYG
     DSIPRLAAED EILSLFPATP LQTGMLSQTI YSGGRLYMVH HSLQLDINTV SLERLRNAWE
     VVVASTDILR CSFHVCPSGD YPWLAAIHSK TPLRWKEYDV PSTSVLRLIA FQIENTELIK
     DESGFATPPL SLHLINSPDM CVLIISMHHC LYDGLSLAYI LEDVTAAYFG HEAVRRPQFT
     DAVPFVLYSS KDRAHFWQKR LSGFSASPIP KRQPEGHSPN LASQFVDLPD GSLDAIKEMG
     VLVQATALLA WGKTLAALTG SLDVVFGQVV AGRAIELDNA LLVNGPLFNT VPFRFTISDP
     SWSNAEGVQA QHAFNIAAEP HSHVPLRTIQ AEWRSQNMSR DTLFDTLFVF QQGKGPSMSS
     LWTRFNVSDD ASASQYPLSL EIIHTNNKIE LRAGCQAGIM SQTELQDLLR LLHDTLLDIV
     VHPTANILDQ SPSLKDLHTV PQHRAPSAQE GHSKSPGRAL TVNEETLRDV FSSVTKIPKD
     QIGLETPLYA LGLDSVGAIQ VAAKCRIDGL NITVVDIFAG ETIAGICKAY ETRDIPETGT
     LLEPSELVSS NIRDKALALL NLEQESVQEV LPVLAGQSYH LGAWLACGGI SYEPVFAYRA
     AVPLDPERLR KAWNALRSQH GILRTSFAAT SPDEVVQVVL KQLPDSDPSW SFVEVEGDFD
     QRVREQARIE YSRPSTLFRP PARARLVRVG NQDALLLVFH HATYDAWSIP LLVRDLCALY
     DGLHCKSTSN FTGLVQYLHT TSDKGSQATF WRDSLDADSG VRPTILPTTS PSSGLKQVFV
     RVPGVVSSVD QLSNRCQTAG VGLQALVLAV WGRVCQNLIR STSAPILGVY HTGRAASFDG
     LGELAGPTVN VLPMRVPVAS PGKIWDVAKQ IQRDLGRRTA FEHSSLREIM SHVGHKNGPL
     FNVFVNLLWH GDKIRTIRQD SLLSSLSIGP PTDYAPDKPF ALKSSVNALD HSHLPKFGLY
     IDVVLDSKDQ SLAVAARCHE ALLNKEQLRS VVDSFGDGVV DAIGELE
//
